MPO about drug discovery

I have question about MPO multi-parameter optimisation in drug discovery.
My opinion is that designed molecule’s biological activity and ADMET profile are not always correlate.
So, to design molecules that has good profile, I think it is important to get data about molecules not only biological activity but also phys-chem and ADMET profile even if a molecule does not have high potency about primary target.

Water-flall cascade system, for example check biological activity at first, then check in vitro phy-schem, and ADMET profile, next in vivo PK….. works good for filter low potency molecules but we lost chance to get any molecular property information. And also need more time I think.

I proposed parallel approach that check biological activity and HTS PADMET data at the same time.
Is that system waste of resources ?

I know it’s difficult to do MPO in drug discovery, but we have to do that.
I’m still finding the answer….


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.